Sermorelin: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 120 community reports
- โข4 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Dosing Range | Clinical studies used sermorelin at doses of 1-2 mg/day subcutaneously. The FDA-approved Geref dosing for diagnostic use was 1 mcg/kg IV. Therapeutic studies typically used 30 mcg/kg/day SC. | Community doses range widely from 100 mcg to 1000 mcg daily SC. The most popular range is 200-300 mcg nightly, significantly lower than clinical study doses. Some clinic-prescribed protocols use 500-1000 mcg. | moderate Community doses at the lower end (200-300 mcg) are below typical clinical study doses. Users report that even lower doses produce subjective improvements in sleep and recovery. |
| Treatment Duration | Clinical trials typically ran 6-12 months. The Vittone 1997 study examined sermorelin over 16 weeks. Pediatric GH deficiency studies ran for up to 2 years. | Users commonly run 3-6 month initial courses followed by maintenance dosing 2-3 times per week. Some users report continuous use for over a year. Cycling patterns (5 days on, 2 off) are popular. | moderate Community cycling patterns (5 on/2 off) are not derived from clinical protocols but are believed to prevent pituitary desensitization. |
| Timing of Administration | Clinical studies generally administered sermorelin without strict timing requirements relative to meals or sleep. | Community strongly emphasizes bedtime dosing on an empty stomach (no carbs for 1-2 hours prior). Users believe fasting state and alignment with nocturnal GH pulses are critical for efficacy. | moderate The emphasis on fasted bedtime dosing is community-derived and based on the rationale that insulin and blood glucose suppress GH release. This has some physiological basis but is not specifically validated for sermorelin timing. |
| Combination with GHRPs | Published research has studied sermorelin alone or with GHRP-2 in limited settings. No large clinical trials have evaluated sermorelin combined with ipamorelin. | The sermorelin + ipamorelin combination is one of the most popular GH-boosting stacks in the community. Users report synergistic effects from combining a GHRH analog with a GHRP. | high While the mechanistic rationale for combining GHRH and GHRP pathways is sound (they activate complementary pathways), the specific sermorelin + ipamorelin combination lacks clinical trial validation. |
Compare these community approaches with published research findings.
Community Protocols
Standard Nighttime Protocol
Popular- Route
- Subcutaneous
- Dose
- 200-300 mcg
- Frequency
- Once daily (before bed)
- Duration
- 3-6 months
Most commonly reported protocol; injected 30-60 minutes before sleep on an empty stomach to align with natural GH pulsatility
Clinical/Compounding Pharmacy Protocol
Common- Route
- Subcutaneous
- Dose
- 500-1000 mcg
- Frequency
- Once daily (before bed)
- Duration
- 6-12 months
Higher dose often prescribed by anti-aging and TRT clinics; 1 mg dose reported as maximum pituitary stimulation threshold
Sermorelin + Ipamorelin Stack
Popular- Route
- Subcutaneous
- Dose
- 200-300 mcg each
- Frequency
- Once daily (before bed)
- Duration
- 3-6 months
Combined GHRH + GHRP protocol targeting both GH-releasing pathways; five days on, two days off cycling common
Maintenance Protocol
Common- Route
- Subcutaneous
- Dose
- 500-1000 mcg
- Frequency
- 2-3 times per week
- Duration
- Ongoing
Used after initial daily loading phase of 3-6 months; reduced frequency to maintain elevated IGF-1 levels
Stacking Patterns
Sermorelin + Ipamorelin GH Stack
PopularCombined GHRH + GHRP stimulation for enhanced GH pulse; sermorelin activates the GHRH receptor while ipamorelin acts as a ghrelin mimetic on the GHS-R1a receptor
Sermorelin + GHRP-2 Stack
CommonAlternative GHRH + GHRP combination; GHRP-2 provides stronger GH release than ipamorelin but with more appetite stimulation and potential cortisol elevation
Sermorelin + CJC-1295 Transition
NicheSome users transition from sermorelin to CJC-1295 DAC for longer-acting effects, or use CJC-1295 no-DAC as a more potent GHRH analog alternative
Sermorelin + BPC-157 Recovery Stack
NicheGH stimulation combined with injury healing; sermorelin for systemic recovery support and BPC-157 for targeted tissue repair
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 120+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|Sermorelin protocol and dosing discussions(accessed 2026-02-16)
- Reddit r/PeptideResearch|Sermorelin experience reports and GHRH analog comparisons(accessed 2026-02-16)
- Excel Male Forum|Sermorelin - What's Your Experience? (multi-year discussion thread)(accessed 2026-02-16)
- Excel Male Forum|Sermorelin Guidelines for Therapy/Protocol(accessed 2026-02-16)
- GLP-1 Forum|Sermorelin discussion thread(accessed 2026-02-16)
- Jay Campbell (Peptide Community)|Sermorelin and Ipamorelin stack protocol guide(accessed 2026-02-16)
- Peptide Initiative|Sermorelin Dosing Protocol - Clinical Guidelines(accessed 2026-02-16)
- Swolverine|Sermorelin for Bodybuilding dosage and timing insights(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for Sermorelin. The information below is gathered from peptide research forums, Reddit communities, anti-aging clinic patient reports, and self-experimenter communities. This is not clinical evidence and should not be used as medical guidance.
Sermorelin is one of the most widely discussed growth hormone secretagogues in peptide communities. As a previously FDA-approved peptide (marketed as Geref for GH deficiency diagnosis), it benefits from a foundation of clinical legitimacy that many other peptides lack. It remains widely available through compounding pharmacies and online peptide vendors, and is commonly prescribed by anti-aging and hormone optimization clinics.
Understanding Protocol Divergence#
Dosing Differences#
The most significant divergence between clinical research and community use involves dosing. Clinical studies typically used sermorelin at 1-2 mg/day (1000-2000 mcg), while the most popular community protocol uses only 200-300 mcg nightly. This lower dose range appears to have been adopted through community dose-finding over time, with users reporting that 200-300 mcg provides noticeable subjective benefits (improved sleep, recovery) without the cost of higher doses. Some compounding pharmacy protocols prescribe the higher 500-1000 mcg range, which is closer to clinical study doses.
Timing and Fasting#
Community protocols strongly emphasize bedtime administration on an empty stomach, typically requiring no carbohydrate intake for 1-2 hours before injection. This practice is based on the well-established physiology that insulin suppresses GH release and that the largest endogenous GH pulse occurs during early deep sleep. While this rationale has scientific basis, no studies have specifically compared fasted versus fed sermorelin administration timing.
Cycling Patterns#
Many community members follow a 5-day-on, 2-day-off cycling pattern, believed to prevent pituitary desensitization. After an initial daily dosing phase of 3-6 months, users commonly transition to a maintenance protocol of 2-3 injections per week. These cycling patterns are community-derived and not based on clinical trial protocols.
Commonly Reported Outcomes#
Community members frequently report the following when using sermorelin:
- Sleep quality: The most consistently reported benefit, with users describing deeper sleep and more vivid dreams within the first 1-2 weeks
- Recovery: Improved recovery from exercise and workouts, typically noticed at 3-4 weeks
- Skin and hair: Some users report improvements in skin elasticity and hair quality over 2-3 months
- Body composition: Gradual improvements in lean mass and fat distribution over 3-6 months
- IGF-1 levels: Users who test report average IGF-1 increases of 20-30% from baseline over 2-4 weeks
- Energy levels: Many report improved daytime energy and reduced fatigue
Commonly Reported Side Effects#
- Injection site reactions: Redness, itching, or welting at the injection site (common, usually transient)
- Flushing and warmth: Some users report facial flushing or a warm sensation after injection
- Headache: Occasional headaches, particularly in the first week
- Water retention: Mild fluid retention reported by some users, similar to other GH-stimulating peptides
Important Caveats#
- These are self-reported outcomes without controls, blinding, or objective measurement
- Placebo effect and concurrent lifestyle changes confound interpretation
- Sermorelin was FDA-approved only as a diagnostic agent (Geref), not for anti-aging or body composition
- Product quality varies significantly between compounding pharmacies and peptide vendors
- Users who experience dramatic results are more likely to post about them (publication bias)
Reconstitution and Storage Practices#
Community reconstitution practices for sermorelin generally follow standard peptide handling:
- Reconstitution: 1-2 mL bacteriostatic water per 2-5 mg vial
- Storage: Reconstituted solution refrigerated at 2-8 degrees C
- Shelf life: Most users report using reconstituted sermorelin within 3-4 weeks
- Injection volume: Typically 0.1-0.3 mL per injection depending on concentration
- Injection sites: Abdominal subcutaneous fat is most common
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About Sermorelin
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.